What's Happening?
Dr. Daniel Hornburg of Bruker Daltonics discusses the advancements in functional proteomics, which is reshaping precision medicine by providing deeper insights into protein functions and interactions. Unlike genomics, which offers a static view of biological
potential, proteomics provides real-time data on cellular activities. The timsOmni™ platform introduced by Bruker allows for detailed mapping of proteoforms, the various structural variants of proteins produced by a single gene. This technology enables researchers to understand the complexity of the proteome and its role in health and disease, offering new avenues for personalized medicine.
Why It's Important?
Functional proteomics is becoming a critical tool in precision medicine, offering insights that genomics alone cannot provide. By understanding the specific proteoforms and their interactions, researchers can develop more targeted therapies for diseases like cancer. This approach allows for the identification of biomarkers and therapeutic targets that are crucial for personalized treatment plans. The ability to map proteins at a single-cell level and maintain spatial context enhances the understanding of complex biological systems, potentially leading to breakthroughs in disease treatment and drug development.
What's Next?
The future of functional proteomics involves integrating this technology into routine clinical practice, making it a standard tool for disease diagnosis and treatment planning. As the technology becomes more accessible and scalable, it is expected to play a significant role in drug discovery and safety screening. The continued development of platforms like timsOmni™ will facilitate the transition from research to clinical application, ultimately improving patient outcomes through more precise and effective treatments.
